New hope for HIV patients with kaposi sarcoma: drug shows promise in africa
NCT ID NCT03601806
First seen Jan 06, 2026 · Last updated Apr 29, 2026 · Updated 16 times
Summary
This study tested a drug called pomalidomide in 26 HIV-positive people with Kaposi sarcoma, a type of skin cancer. The drug works by boosting the immune system and blocking blood vessel growth to tumors. The goal was to see if the drug could shrink or eliminate the cancer while monitoring side effects. Participants were from Sub-Saharan Africa and continued their HIV treatment during the study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN KAPOSI SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moi University School of Medicine
Eldoret, Kenya
-
UNC Project Malawi
Lilongwe, Malawi
-
Uganda Cancer Institute
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.